From ADT and EBRT to PSA, we’ve compiled definitions for a variety of terms you may come across during your prostate cancer journey.
Company News
A prostate cancer diagnosis can be overwhelming and often confusing. PHENPath.com provides patients relevant and detailed information, including this glossary of important terms.
December 30th, 2020 | Company NewsTreatment options for men newly diagnosed with prostate cancer are based on their risk level. Visit PHENPath.com to learn more about the various risk levels assigned to your diagnosis.
December 17th, 2020 | Company News
Prostate Cancer tests can include several options. PHENPath.com provides a detailed overview of the various tests and what to anticipate after diagnosis.
December 2nd, 2020 | Company News
Prostate Cancer testing may include imaging tests, CT, MRI, PET or Bone scans, ultrasounds and/or Blood, tissue, genetic, Germline or Tumor testing. Click the button below to learn more about these processes.
PHENPath helps prostate cancer patients to understand their treatment pathways and treatment options.
November 23rd, 2020 | Company News
Welcome to PHENPath.com – Where we provide Treatment Pathways and Treatment Options to Prostate Cancer Patients
November 10th, 2020 | Company News
Recent Posts
The Jackson, Mississippi Prostate Cancer Disparity Rally mobilized leaders to record prostate cancer awareness messages.- PHENPath.com – Empowering Patients
- PHEN Supports Talapro-3 Clinical Trial
- The FDA approves a new prostate cancer combination treatment based upon a successful clinical trial
- If you are experiencing PSA recurrence after surgery, PHENPath.com provides information about available treatment options as set forth by NCCN Guidelines®
